Potentiation of Insulin Secretory Responses by Plasma Glucose Levels in Man: Evidence That Hyperglycemia in Diabetes Compensates for Impaired Glucose Potentiation*
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Insulin secretory responses to nonglucose stimuli may be of normal magnitude in maturity-onset diabetics (MOD). We have used the β-adrenergic agent isoproterenol as a tool to assess the role of basal hyperglycemia in maintaining these islet responses of MOD. The acute insulin responses (AIR; mean Δ 2- to 4-min immunoreactive insulin) to 12 μg isoproterenol increased in eight MOD and eight controls when plasma glucose (PG) levels were increasedby glucose infusions. Although increases of PG were similar in the two groups, differences ofAIR of controls vs. those of MOD were magnified during glucose infusion: AIR, 40 ± 8vs. 20 ± 15 μU/ml,(mean ± SEM), P < 0.05, baseline; and 263 ± 56 vs. 60 ± 20, P < 0.01, 900 mg/min glucose infusion. Conversely, infusion of insulin for 2 h lowered PG and inhibited the AIR to isoproterenol in six controls (Δglucose, -11 ± 2 mg/dl; AAIR, -15 ± 3μU/ml, P < 0.01 vs. baseline AIR) and six MOD (Δglucose, -112 ± 21; ΔAIR, -11 ± 4, P < 0.05). For each subject, the potentiating effect of glucose on the AIR to isoproterenol was expressed as the slopeof the relationship between ΔPG from the fasting PG level and ΔAIR from the baseline AIR. These slopes of potentiation were lower in MOD than in controls (0.16 ± 0.06 vs. 1.58 ± 47; P < 0.01) and declined monoexponentially as the fasting PG level of each subjectincreased (r = -0.87; P < 0.001). These findings indicate that the AIR to isoproterenol isregulated by the PG level, but that this potentiating effect of glucose isimpaired in MOD. The relationship between the degree of impairment (as assessed by the slope of potentiation) and the fasting PG level suggests that the presence of basal hyperglycemia in MOD tends to preserve islet responsiveness to nonglucose stimuli. We hypothesize that, in asimilar manner, basal hyperglycemia may compensate for abnormal glucose regulation of basal insulin secretion in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*
Perley, M. J., & Kipnis, D. M. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105685 · Cited by 917
Bagdade, J. D., Bierman, E. L., & Porte, D. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105646 · Cited by 672
Self-citationGerich, J. E., Charles, M. A., & Grodsky, G. M. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107823 · Cited by 230
Insulin responses to glucose: evidence for a two pool system in man
Porte, D., & Pupo, A. A. (1969) · Journal of Clinical Investigation · doi:10.1172/jci106197 · Cited by 219
Self-citationPEDERSON, R. A., & BROWN, J. C. (1978) · Endocrinology · doi:10.1210/endo-103-2-610 · Cited by 156
Efendić, S., Luft, R., & Cerasi, E. (1978) · Diabetes · doi:10.2337/diab.27.3.319 · Cited by 23
Glucose control of basal insulin secretion in diabetes
McCarthy, S. T., Harris, E., & Turner, R. C. (1977) · Diabetologia · doi:10.1007/bf00745134 · Cited by 18
Cited by
Reduced incretin effect in Type 2 (non-insulin dependent) diabetes
Nauck, M., Stöckmann, F., Ebert, R., & Creutzfeldt, W. (1986) · Diabetologia · doi:10.1007/bf02427280 · Cited by 1,307
“Arguing against this explanation, intravenous isoproterenol [ 36 ] or glucagon [37] enhanced, rather than diminished, additional B cell secretory responses in Type 2 diabetic patients when plasma glucose levels had been elevated by glucose infusion up to the range employed in our study.”
ResultPacini, G., & Bergman, R. N. (1986) · Computer Methods and Programs in Biomedicine · doi:10.1016/0169-2607(86)90106-9 · Cited by 695
The Importance of β-Cell Failure in the Development and Progression of Type 2 Diabetes
Kahn, S. E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7713 · Cited by 660
Impaired Glucose Tolerance as a Disorder of Insulin Action
Lillioja, S., Mott, D. M., Howard, B. V., Bennett, P. H., Yki-Järvinen, H., Freymond, D., Nyomba, B. L., Zurlo, F., Swinburn, B., & Bogardus, C. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805123181901 · Cited by 578
Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus
Ward, W. K., Bolgiano, D. C., McKnight, B., Halter, J. B., & Porte, D. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111542 · Cited by 483
“The first, the glucose potentiation slope, is the change in acute insulin response to arginine per unit change in glucose level in the linear (low) range of the dose-response-curve, and has been utilized as a measure of B cell responsiveness to glucose level (2).”
BackgroundMethodSelf-citation
Metadata
- Authors
- HALTER, J. B., GRAF, R. J., & PORTE, D.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1979-06
- Volume
- 48
- Issue
- 6
- Pages
- 946-954
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2039266481
- Cited by
- 153
- References
- 7
- FWCI
- 9.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Potentiation of Insulin Secretory Responses by Plasma Glucose Levels in Man: Evidence That Hyperglycemia in Diabetes Compensates for Impaired Glucose Potentiation*. https://app.cochat.ai/papers/10.1210/jcem-48-6-946
- The paper
- HALTER, J. B., GRAF, R. J., & PORTE, D. (1979). Potentiation of Insulin Secretory Responses by Plasma Glucose Levels in Man: Evidence That Hyperglycemia in Diabetes Compensates for Impaired Glucose Potentiation*. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem-48-6-946
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.